Muscarinic, but not nicotinic, acetylcholine receptor blockade in the ventral tegmental area attenuates cue-induced sucrose-seeking

•We examined cue-induced sucrose-seeking during blockade of VTA AChRs or NMDARs.•VTA scopolamine infusion attenuated cue-induced sucrose-seeking.•VTA mecamylamine infusion did not alter cue-induced sucrose-seeking.•VTA AP5 infusion did not alter cue-induced sucrose-seeking. The mesolimbic dopamine (...

Full description

Saved in:
Bibliographic Details
Published inBehavioural brain research Vol. 291; pp. 372 - 376
Main Authors Addy, Nii A., Nunes, Eric J., Wickham, Robert J.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 15.09.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•We examined cue-induced sucrose-seeking during blockade of VTA AChRs or NMDARs.•VTA scopolamine infusion attenuated cue-induced sucrose-seeking.•VTA mecamylamine infusion did not alter cue-induced sucrose-seeking.•VTA AP5 infusion did not alter cue-induced sucrose-seeking. The mesolimbic dopamine (DA) system is known to play a role in cue-mediated reward-seeking for natural rewards and drugs of abuse. Specifically, cholinergic and glutamatergic receptors in the ventral tegmental area (VTA) have been shown to regulate cue-induced drug-seeking. However, the potential role of these VTA receptors in regulating cue-induced reward seeking for natural rewards is unknown. Here, we examined whether blockade of VTA acetylcholine receptors (AChRs) and N-methyl-d-aspartate receptors (NMDARs) would alter cue-induced sucrose seeking in male Sprague-Dawley rats. Subjects underwent 10 days of sucrose self-administration training (fixed ratio 1 schedule) followed by 7 days of forced abstinence. On withdrawal day 7, rats received bilateral VTA infusion of vehicle, the muscarinic AChR antagonist scopolamine (2.4 or 24μg/side), the nicotinic AChR antagonist mecamylamine (3 or 30μg/side), or the NMDAR antagonist AP-5 (0.1 or 1μg/side) immediately prior to examination of cue-induced sucrose-seeking. Scopolamine infusion led to robust attenuation, but did not completely block, sucrose-seeking behavior. In contrast, VTA administration of mecamylamine or AP-5 did not alter cue-induced sucrose-seeking. Together, the data suggest that VTA muscarinic AChRs, but not nicotinic AChRs nor NMDARs, facilitate the ability of food-associated cues to drive seeking behavior for a food reward.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0166-4328
1872-7549
DOI:10.1016/j.bbr.2015.05.036